These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 27592369)

  • 1. Increased serum levels of tumor necrosis factor receptor-associated factor 1 (TRAF1) correlate with disease activity and autoantibodies in rheumatoid arthritis.
    Cheng T; Sun X; Wu J; Wang M; Eisenberg RA; Chen Z
    Clin Chim Acta; 2016 Nov; 462():103-106. PubMed ID: 27592369
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elevated serum and synovial fluid TNF-like ligand 1A (TL1A) is associated with autoantibody production in patients with rheumatoid arthritis.
    Sun X; Zhao J; Liu R; Jia R; Sun L; Li X; Li Z
    Scand J Rheumatol; 2013; 42(2):97-101. PubMed ID: 23311967
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor necrosis factor receptor-associated factor 1 influences KRN/I-Ag7 mouse arthritis autoantibody production.
    Cheng T; Choi Y; Finkel TH; Tsao PY; Ji MQ; Eisenberg RA
    J Clin Immunol; 2013 May; 33(4):759-66. PubMed ID: 23354839
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The role of anti-cyclic citrullinated peptide (anti-CCP) antibodies in serologic diagnosis and evaluation of disease activity in rheumatoid arthritis].
    Aridoğan BC; Kaya S; Savaş S; Cetin ES; Akkuş S; Demirci M
    Mikrobiyol Bul; 2008 Oct; 42(4):669-74. PubMed ID: 19149089
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A candidate gene approach identifies the TRAF1/C5 region as a risk factor for rheumatoid arthritis.
    Kurreeman FA; Padyukov L; Marques RB; Schrodi SJ; Seddighzadeh M; Stoeken-Rijsbergen G; van der Helm-van Mil AH; Allaart CF; Verduyn W; Houwing-Duistermaat J; Alfredsson L; Begovich AB; Klareskog L; Huizinga TW; Toes RE
    PLoS Med; 2007 Sep; 4(9):e278. PubMed ID: 17880261
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Susceptibility variants for rheumatoid arthritis in the TRAF1-C5 and 6q23 loci: a meta-analysis.
    Patsopoulos NA; Ioannidis JP
    Ann Rheum Dis; 2010 Mar; 69(3):561-6. PubMed ID: 19401279
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of the TRAF1/C5 locus with increased mortality, particularly from malignancy or sepsis, in patients with rheumatoid arthritis.
    Panoulas VF; Smith JP; Nightingale P; Kitas GD
    Arthritis Rheum; 2009 Jan; 60(1):39-46. PubMed ID: 19116907
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-cyclic citrullinated peptide antibody and rheumatoid factor isotypes in Iranian patients with rheumatoid arthritis: evaluation of clinical value and association with disease activity.
    Shakiba Y; Koopah S; Jamshidi AR; Amirzargar AA; Massoud A; Kiani A; Nicknam MH; Nazari B; Nikbin B
    Iran J Allergy Asthma Immunol; 2014 Jun; 13(3):147-56. PubMed ID: 24659118
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of serum angiopoietin-1 measurement in the diagnosis of early rheumatoid arthritis.
    Ishikawa A; Okada J; Nishi K; Hirohata S
    Clin Exp Rheumatol; 2011; 29(4):604-8. PubMed ID: 21906428
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of TRAF1/C5 and STAT4 genes polymorphisms on susceptibility and severity of rheumatoid arthritis in Egyptian population.
    Mohamed RH; Pasha HF; El-Shahawy EE
    Cell Immunol; 2012; 273(1):67-72. PubMed ID: 22196377
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TRAF1 gene polymorphism correlates with the titre of Gp210 antibody in patients with primary biliary cirrhosis.
    Kempinska-Podhorodecka A; Shums Z; Wasilewicz M; Wunsch E; Milkiewicz M; Bogdanos DP; Norman GL; Milkiewicz P
    Clin Dev Immunol; 2012; 2012():487521. PubMed ID: 23125866
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulating Interferon-Inducible Protein IFI16 Correlates With Clinical and Serological Features in Rheumatoid Arthritis.
    Alunno A; Caneparo V; Bistoni O; Caterbi S; Terenzi R; Gariglio M; Bartoloni E; Manzo A; Landolfo S; Gerli R
    Arthritis Care Res (Hoboken); 2016 Apr; 68(4):440-5. PubMed ID: 26316393
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autoantibodies against interleukin-21 correlate with disease activity in patients with rheumatoid arthritis.
    Xing R; Sun L; Wu D; Jin Y; Li C; Liu X; Zhao J
    Clin Rheumatol; 2018 Jan; 37(1):75-80. PubMed ID: 29019047
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autoantibodies in prediction of the development of rheumatoid arthritis among healthy relatives of patients with the disease.
    Ramos-Remus C; Castillo-Ortiz JD; Aguilar-Lozano L; Padilla-Ibarra J; Sandoval-Castro C; Vargas-Serafin CO; de la Mora-Molina H; Ramos-Gomez A; Sanchez-Ortiz A; Avila-Armengol H; Aceves-Avila FJ
    Arthritis Rheumatol; 2015 Nov; 67(11):2837-44. PubMed ID: 26245885
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A genetic study on C5-TRAF1 and progression of joint damage in rheumatoid arthritis.
    van Steenbergen HW; Rodríguez-Rodríguez L; Berglin E; Zhernakova A; Knevel R; Ivorra-Cortés J; Huizinga TW; Fernández-Gutiérrez B; Gregersen PK; Rantapää-Dahlqvist S; van der Helm-van Mil AH
    Arthritis Res Ther; 2015 Jan; 17(1):1. PubMed ID: 25566937
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Relationship of Cytokines IL-13 and IL-17 with Autoantibodies Profile in Early Rheumatoid Arthritis.
    Siloşi I; Boldeanu MV; Cojocaru M; Biciuşcă V; Pădureanu V; Bogdan M; Badea RG; Avramescu C; Petrescu IO; Petrescu F; Siloşi CA
    J Immunol Res; 2016; 2016():3109135. PubMed ID: 27579330
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of anti-mutated citrullinated vimentin, anti-cyclic citrullinated peptides, anti-glucose-6-phosphate isomerase and anti-keratin antibodies and rheumatoid factor in the diagnosis of rheumatoid arthritis in Chinese patients.
    Zhu T; Feng L
    Int J Rheum Dis; 2013 Apr; 16(2):157-61. PubMed ID: 23773638
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Soluble receptors for tumor necrosis factor and interleukin-2 in serum and synovial fluid of patients with rheumatoid arthritis, reactive arthritis and osteoarthritis.
    Steiner G; Studnicka-Benke A; Witzmann G; Höfler E; Smolen J
    J Rheumatol; 1995 Mar; 22(3):406-12. PubMed ID: 7783054
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-MBL autoantibodies in patients with rheumatoid arthritis: prevalence and clinical significance.
    Gupta B; Raghav SK; Agrawal C; Chaturvedi VP; Das RH; Das HR
    J Autoimmun; 2006 Sep; 27(2):125-33. PubMed ID: 16904869
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Associations between serum anti-CCP antibody, rheumatoid factor levels and HLA-DR4 expression in Hungarian patients with rheumatoid arthritis.
    Kapitány A; Szabó Z; Lakos G; Aleksza M; Végvári A; Soós L; Karányi Z; Sipka S; Szegedi G; Szekanecz Z
    Isr Med Assoc J; 2008 Jan; 10(1):32-6. PubMed ID: 18300568
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.